December 8, 2022

Enteq Technologies Investor Presentation 2023

Enteq Technologies Plc (LON:NTQ) Chief Executive Officer Andrew Law talks us through the 2023 Investor Presentation and latest interim results. Enteq Technologies (LON: NTQ) develops technologies..

Touchstone Exploration to accelerate exploration, development and production opportunities (VIDEO)

Touchstone Exploration Inc. (LON:TXP) Chief Executive Officer Paul Baay joins DirectorsTalk Interviews to discuss placings in both Canada and the UK. Paul explains how the funds..

Tern investee Wyld Network launches its satellite IoT network

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has noted that Wyld Networks AB has today announced the launch..

DS Smith revenues increase 28% to £4,299m

DS Smith plc (LON:SMDS) has announced its 2022/23 half year results. 6 months to 31 October 2022Continuing operations Change(reported) Change(constant currency) Revenue £4,299m +28% +26% Adjusted..

British American Tobacco expect to deliver strong adjusted operating margin improvement

British American Tobacco plc (LON:BATS) has announced its 2022 second half pre-close trading update. FY 2022 guidance: o  Revenue growth of 2% to 4% at constant currency..

Aferian full year numbers in line with recently stated guidance

Aferian plc (LON:AFRN), the B2B video streaming solutions company, has provided today a trading update for the year ended 30 November 2022. The Group confirms that..

Falanx Group report progress in sales with good order growth

Falanx Group Limited (LON:FLX), the AIM listed provider of cyber security services, has announced today its interim results for the six months ended 30 September 2022...

Tern Plc raises £1.5 million for follow-on investment opportunities

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, has announced that it has raised £1.5 million, before expenses,..

Allergy Therapeutics provides key updates on Grass MATA MPL and VLP Peanut clinical programmes

Allergy Therapeutics (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced that the first subject has been dosed in the pivotal Phase..

Search

Funds

December 8, 2022

Search

Funds

December 8, 2022

FTSE 100

Funds